Home > Boards > US OTC > Medical - Equipment >

Connectyx Techs Hldg (CTYX)

CTYX RSS Feed
Add CTYX Price Alert      Hide Sticky   Hide Intro
Moderator: i_like_bb_stock, Eagle1, pepeoil, skichic, maz1978 , trader59
Search This Board: 
Last Post: 12/2/2020 2:24:28 PM - Followers: 311 - Board type: Free - Posts Today: 3



Share Structure

Authorized Shares 1,100,000,000 12/12/2019
Outstanding Shares 322,800,327 03/03/2020
Restricted 125,836,588 03/03/2020
Unrestricted 196,963,739 03/03/2020
Held at DTC 188,707,258 03/03/2020









It's now official, CTYX is no longer s shell! First otcmarkets was updated with new officers and directors as well as the company's address. Then their Florida SOS was updated to include the updates.
Now we have an official PR. 


OTC Profile:
https://www.otcmarkets.com/stock/CTYX/profile

SOS update:
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=CONNECTYXTECHNOLOGIESHOLDINGSG%20P070001187070&aggregateId=domp-p07000118707-cd4afd40-6c64-433b-9f3e-72eccc2ec9b6&searchTerm=Connectyx%20Technologies%20Holdings%20Group%2C%20Inc.&listNameOrder=CONNECTYXTECHNOLOGIESHOLDINGSG%20P070001187070

http://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-p07000118707-cd4afd40-6c64-433b-9f3e-72eccc2ec9b6&transactionId=p07000118707-88db6848-a7a9-4873-9341-bb4668d4a40d&formatType=PDF

Official PR:
Connectyx Technologies Holdings Group announces Shareholder Update

March 06, 2020 09:30 ET | Source: Connectyx Technologies Holdings Group, Inc

BOCA RATON, FL, March 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group (OTC PINK: CTYX) issued a shareholder update today regarding recent corporate developments including management and Board of Director changes.

SunMed Advisors, LLC has recently acquired majority control of CTYX through the purchase of Series A Preferred stock from the two principal holders of CTYX.

Jon Pevzner, former President and Director, has resigned and Paul M. Michaels was appointed Interim CEO and Director. Mr. Michaels has business and investment experience in Japan and the U.S. with noteworthy expertise in the Life Sciences sector. He has completed transactions involving companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and Gilead Sciences.

Dr. Barry A. Ginsberg and Brandon Michaels join Mr. Michaels on the Board.

CTYX is currently in the process of updating financials to become compliant with OTCMarkets and has appointed Jonathan D. Leinwand, PA as Legal Counsel.

CTYX will continue to update shareholders on a new business plan through news releases, website updates and OTCMarkets filings as the company moves forward.

Investor Database for Future Press Releases and Industry Updates

Interested investors and shareholders are invited to be added to the corporate e-mail database for corporate press releases and periodic industry updates by sending an e-mail to: investorrelations@connectyx.com

About SunMed Advisors, LLC ( https://sunmedadvisors.com/ )

SunMed Advisors is a Life Science and Technology consulting firm that helps create maximum corporate value with strategic initiatives and a leading advisor on Pre-Commercial and Commercial-Stage licensing deals. SunMed brings value to all stages of licensing transactions, from sourcing through closing.
 
This part of the IBOX is being managed by RiseandShine follow me on twitter  https://twitter.com/Rise2ShineLife 


 25 year Investment Banker and Harvard Business Graduate Paul M Michaels is here!  

PAUL M. MICHAELS

For the past two decades, Mr. Michaels has established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field. He has completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and Gilead, to name just a few.

Paul has also provided financial leadership for almost 18 years to Inabata & Co. Ltd., one of Japan’s largest trading companies with $4.5 billion in annual sales and successfully licensed multiple drugs from Gilead (formerly Nexstar Pharmaceuticals). Throughout his tenure, he structured and closed major transactions that brought high-value products to the Japanese pharmaceutical market in addition to other corporate responsibilities that included overall evaluation of corporate asset values. Paul subsequently founded Nobelpharma, Ltd. Japan, an affiliate of Inabata & Co. Ltd., which is now one of Japan’s most profitable orphan drug companies. As President of the U.S. division and a co-Founder,he secured $35 million in initial capital and negotiated the license for the first designated orphan drug product in the company’s pipeline from Teva Pharmaceuticals.

Paul began his career as Co-Founder, Executive Vice President and Board Member of Global Capital Group, a publicly traded corporate finance firm on Wall Street where he structured, financed and advised transactions in multiple spaces utilizing a variety of financial vehicles including private placements and Initial Public Offerings.

He received his Bachelor’s degree from Tulane University and completed an HBX program from Harvard.

Paul has completed transactions that influenced companies such as Celgene Corporation.


Paul is responsible for opening up the Japanese market to US drug companies
Inabata Pharmaceuticals becomes a significant provider of pharmaceuticals and API and merges with Sumitomo Pharmaceuticals in 1983. Licensing activity begins in 1996 with Sumitomo Pharmaceuticals, through the negotiations of Investment Banker, Paul M. Michaelslicenses Ambisome and Danisome for the Asian marketplace from a U.S. Pharmaceutical company. This is the beginning of business licensing U.S. developed drugs for the Japanese market. Additionally, an Orphan drug business is created with the assistance of Paul M. Michaels with his Japanese counterparts called Nobelpharma. Co.LtdThe first licensed product, from Teva Pharmaceuticals USA, is for the treatment of Wilson's disease in Japan. This transaction was negotiated and completed by Paul Michaels.






 

CTYX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTYX News: PAOG Cannabis Drug Company Trends Bullish - $0.01 Breakout On Horizon? 10/21/2020 09:59:39 AM
CTYX News: Fintech SPAC Boom Could Ignite Existing Fintechs Like IQST 10/19/2020 11:11:53 AM
PostSubject
#28773  Sticky Note DD on why this is not a game: https://investorshub.advfn.com/boards/read_ RiseandShine 10/31/20 09:31:59 PM
#27738  Sticky Note Big News! https://www.otcmarkets.com/stock/CTYX/news/Connectyx-Announces-Grant-o i_like_bb_stock 10/16/20 03:30:19 PM
#27639  Sticky Note The dump is on... trader59 10/16/20 01:16:04 PM
#27393  Sticky Note Trading bio pharm companies has nothing to do maz1978 10/14/20 08:14:27 AM
#29111   been up for a few weeks now MarkDaShark 12/02/20 02:50:03 PM
#29110   I saw that. “Investor Calendar” caught my eye govprs 12/02/20 02:24:28 PM
#29109   Website has been updated some good things to happen! moczowy 12/02/20 02:01:48 PM
#29108   I added again. We are getting close govprs 12/01/20 03:15:25 PM
#29107   Thanks for the 20k 0276! BCM18 12/01/20 01:20:47 PM
#29106   $CURB LONG!! fat_tire 12/01/20 07:12:02 AM
#29105   Expand what product portfolio? Lol pepeoil 12/01/20 02:40:37 AM
#29104   Love this part “We expect to be announcing govprs 11/30/20 10:17:07 PM
#29103   Fantastic PR tells the story of what’s next. govprs 11/30/20 10:07:57 PM
#29102   News is coming CEO said so a few govprs 11/30/20 09:28:06 PM
#29101   People should learn how prv works and how Fai 2 11/30/20 08:02:49 PM
#29099   Exactly as I stated... Stock_Barber 11/30/20 07:48:07 PM
#29098   Duh! Hihi it clearly states definitive agreement "NEWS SERVICE Connectyx Fai 2 11/30/20 07:08:28 PM
#29097   MOST IMPORTANTLY... Stock_Barber 11/30/20 07:02:29 PM
#29095   Miss informed. Up over 300 percent and holding Fai 2 11/30/20 05:56:51 PM
#29094   CTYX... The timber that never ends... Stock_Barber 11/30/20 05:49:16 PM
#29093   .1 with the next update and substantial volume TimeFades 11/30/20 05:28:34 PM
#29092   There was a 100 (I need shares) just fat_tire 11/30/20 05:26:29 PM
#29091   I saw the 911. I have no idea fat_tire 11/30/20 05:19:54 PM
#29090   Does anyone have a target date for getting edro 11/30/20 04:16:55 PM
#29089   Easy money sub 3s soaking as well TimeFades 11/28/20 09:07:16 AM
#29088   If all goes well,this could be a $120 edro 11/27/20 02:39:36 PM
#29087   I keep adding down here thank you for govprs 11/27/20 12:23:43 PM
#29086   Yes and the company description finally changed on moczowy 11/27/20 09:49:02 AM
#29085   this year im thankful for CTYX soon to MarkDaShark 11/26/20 11:21:33 PM
#29084   He's trying on TSN$ and as usual is Deuces 11/25/20 09:23:22 PM
#29083   With volume silver comes quick . Soaking any TimeFades 11/25/20 08:03:16 PM
#29082   Hey, where'd arrakis, and CopyNpaste go anyway? ;) $CTYX Cuneiform 11/25/20 07:05:25 PM
#29081   Every time this sells down I add. govprs 11/25/20 04:13:03 PM
#29080   This is going so much higher. .20+. Looking alabama96 11/25/20 08:06:02 AM
#29079   you are so right. dounome 11/24/20 09:44:30 PM
#29078   Obviously lol. Finally breaking out of the bull RetroSpect 11/24/20 08:49:32 PM
#29077   Going higher. dounome 11/24/20 04:51:45 PM
#29076   They will be expanding their portfolio.This has Nasdaq edro 11/23/20 03:06:13 PM
#29075   This is moving in the right direction. govprs 11/23/20 02:32:07 PM
#29074   Stay tuned , silver soon TimeFades 11/23/20 12:20:57 PM
#29073   Already been waiting many weeks now it’s more ScottAllen 11/23/20 11:31:58 AM
#29072   More announcements in the coming weeks. Time govprs 11/23/20 11:08:56 AM
#29071   The warrants were priced above current prices on govprs 11/23/20 10:56:53 AM
#29070   agreed i_like_bb_stock 11/23/20 10:52:24 AM
#29069   https://twitter.com/Rise2ShineLife/status/1330896383176548353 RiseandShine 11/23/20 10:37:50 AM
#29068   https://twitter.com/Rise2ShineLife/status/1330896383176548353 RiseandShine 11/23/20 10:37:50 AM
#29067   Some great news developing! This is gonna fly fat_tire 11/23/20 10:36:28 AM
#29066   2 good thing comes out of this CPR. Vanasn 11/23/20 10:29:02 AM
#29065   So on name change they have to cover? Fai 2 11/23/20 10:21:36 AM
#29064   come on price move i_like_bb_stock 11/23/20 10:20:31 AM
#29063   What is Non-Dilutive Funding? Non-dilutive funding refers to any capital a moczowy 11/23/20 10:19:09 AM
#29062   $CTYX=$CURB Big news with no Office! Scuba-D 11/23/20 10:18:07 AM
#29061   CTYX=CURB and Curative Bio soon. Non-Dilutive bridge Scuba-D 11/23/20 10:13:56 AM
#29060   $$$$$$$$ coming! $CTYX LONG!! fat_tire 11/23/20 10:11:00 AM
PostSubject
Consent Preferences